IGC Pharma's total assets for Q2 2025 were $10.37M, a decrease of -2.12% from the previous quarter. DE:IGS1 total liabilities were $2.99M for the fiscal quarter, a 10.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.